Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
Saved in:
| Title: | Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. |
|---|---|
| Authors: | Bacher, U.1, Kern, W.2, Alpermann, T.2, Schnittger, S.2, Kohlmann, A.2, Klein, H.-U.3, Dugas, M.3, Haferlach, C.2, Haferlach, T.2 torsten.haferlach@mll.com |
| Source: | Leukemia (08876924). Aug2011, Vol. 25 Issue 8, p1361-1364. 4p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 08876924 |
|---|---|
| DOI: | 10.1038/leu.2011.80 |
